Stay updated with breaking news from Good Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced it has raised...
Sherlock Biosciences announced today that it raised $80 million in a Series B financing round to support its next-generation diagnostics.
Diagnostics developer Sherlock Biosciences has advanced its molecular diagnostic capabilities, which can now produce faster results on low-cost devices. The startup will use its Series B round of funding to expand the reach of its technology, potentially placing it directly in the hands of consumers around the world.
The company will use the funding to develop diagnostic tests based on CRISPR and synthetic biology that can operate without complex instrumentation.
In part one of this two part posting, I looked at the donors who were ingratiating themselves to Joe Biden by funding his inauguration. In part two, we'll examine who funded his run for the 46th Presidency of the United States, thanks to data provided by Open Secrets. Let's start by…